ALK and inflammatory myofibroblastic tumor: In particular, steroids have proven useful for IMT patients with or without IgG4SD features.[19,8] ALK expression and ALK gene rearrangement have been described as good prognostic markers for IMT, whereas ALK-negative IMT appears to be more aggressive, with a higher frequency of metastasis than ALK-positive tumors.[3,7]